4//SEC Filing
Mattes Glenn R. 4
Accession 0001213900-21-048369
CIK 0001733413other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 1:35 PM ET
Size
5.1 KB
Accession
0001213900-21-048369
Insider Transaction Report
Form 4
Mattes Glenn R.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2021-09-16$7.10/sh+10,000$71,000→ 20,000 total
Holdings
- 7,000(indirect: By Spouse)
Common Stock
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001568678
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 1:35 PM ET
- Size
- 5.1 KB